FDA Purple Book · Reference family
Influenza Vaccine (Afluria, Afluria Quadrivalent)
Influenza Vaccine is an FDA-licensed reference biologic from Seqirus Pty Ltd.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2016
Reference approved
Reference product
351(a)BLA 125254
Afluria, Afluria Quadrivalent Influenza Vaccine
Seqirus Pty Ltd.
- Approved
- Aug 26, 2016
- Marketing
- Disc
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Influenza Vaccine, in chronological order.
Reference approval
Approval date of the reference Influenza Vaccine product.
9 yr 11 mo ago
Frequently asked questions
Are there biosimilars approved for Influenza Vaccine (Afluria, Afluria Quadrivalent)?
No 351(k) biosimilars or interchangeable biosimilars referencing Influenza Vaccine are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.